A Contemporary Overview of PPARα/γ Dual Agonists for the Management of Diabetic Dyslipidemia

BACKGROUND: Diabetes mellitus and concomitant dyslipidemia, being referred to as ‘diabetic dyslipidemia’, are the foremost detrimental factors documented to play a pivotal role in cardiovascular illness. Diabetic dyslipidemia is associated with insulin resistance, high plasma triglyceride levels, lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Balakumar, Pitchai, Mahadevan, Nanjaian, Sambathkumar, Ramanathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875865/
https://www.ncbi.nlm.nih.gov/pubmed/30636619
http://dx.doi.org/10.2174/1874467212666190111165015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875865/
https://www.ncbi.nlm.nih.gov/pubmed/30636619
http://dx.doi.org/10.2174/1874467212666190111165015

Ejemplares similares